Brittenham Marissa's Form 4 filing
Surgery Partners, Inc. (SGRY) · filed Mar 9, 2026
- Accession no.
- 0001638833-26-000019
- Filed
- Mar 9, 2026
- Trade date
- Mar 5-6, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $120.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brittenham MarissaCIK 0001908044 | Officer (Chief Strategy Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Common Stock | SSaleDisposed | −8,785 | $13.70 | −$120,354.5 | 54,623 | Direct | |
| Mar 5, 2026 | Common Stock | AGrant or awardAcquired | +17,717 | $14.11 | +$249,986.87 | 72,340 | Direct | |
| Mar 5, 2026 | Common Stock | AGrant or awardAcquired | +16,363 | $14.11 | +$230,881.93 | 88,703 | Direct | |
| Mar 5, 2026 | Common Stock | AGrant or awardAcquired | +9,150 | $14.11 | +$129,106.5 | 97,853 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.